Deferred registration - Quotient Sciences Code: QSC303684
This Phase 1 clinical trial is designed to test a new medicine in healthy male volunteers aged 30 to 65. Phase 1 trials are the first step in testing a new treatment in people, focusing on safety, tolerability, and how the body handles the medicine. Quotient Sciences is conducting this research in the UK. The specific details about the medicine and exact study procedures are currently listed as 'deferred.' This is a standard regulatory process that allows trial sponsors to protect sensitive research information for a limited time before making all details public. Volunteers in these studies undergo careful health screening to ensure they are safe to take part. While there is no medical benefit to participants, the findings help scientists develop potential new treatments for the future.
At a glance
What is this study about?
Phase 1 clinical trials are an essential early step in the journey of discovering new medicines. Before any new treatment can be offered to patients who are ill, scientists must first test it in a small, carefully monitored group of healthy volunteers. These studies help researchers find out if the drug is safe, what side effects it might cause, and how it is broken down and cleared by the body.
This particular study is being run by Quotient Sciences, a UK-based research organisation that specialises in early-stage trials. The trial title includes the phrase 'deferred registration'. In the UK, research ethics rules allow certain Phase 1 studies in healthy volunteers to delay the publication of their full scientific details. This deferral protects confidential research ideas for a set period, but the trial must still follow strict national safety regulations and ethics committee approvals.
Because this is an early safety trial, only healthy men between the ages of 30 and 65 are being invited to take part. By taking part, healthy volunteers provide vital data that helps doctors determine safe doses for future studies, paving the way for new medicines that may one day treat serious illnesses.
Key takeaways
- Phase 1 trial testing the safety and tolerability of a new medicine.
- Open to healthy male volunteers aged between 30 and 65 years.
- Conducted in the UK by Quotient Sciences.
- Full scientific details are deferred temporarily under standard regulatory rules.
- Participants receive close medical monitoring and compensation for time and travel.
Who may be eligible?
To be considered for this study, you must be a man aged between 30 and 65 years old. You must also be considered a 'healthy volunteer'. In research terms, this generally means you do not have any major long-term illnesses, such as severe heart disease, kidney problems, or active infections.
Because the detailed scientific criteria are deferred, specific medical requirements are not yet publicly listed. However, healthy volunteer studies typically require that you have a healthy body weight, are a non-smoker (or smoke very little), and are not taking regular prescription medications that could interact with the trial drug.
If you contact the trial team, they will discuss the full checklist with you. They will check your medical history and lifestyle habits to see if you can safely take part.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you male?
- Are you between 30 and 65 years old?
- Do you consider yourself in good general health?
- Are you free of major long-term medical conditions?
- Are you able to visit a clinical trial centre for tests and monitoring?
What does participation involve?
Taking part in an early-phase trial usually begins with a screening appointment at a specialist clinic. During this visit, a doctor will review your medical history and carry out basic health checks, such as blood tests, urine tests, and a heart tracing (ECG). If you are accepted into the study, you may be asked to stay overnight at the clinic for one or more days, or attend several short day visits. The study team will give you the trial medicine and closely monitor your heart rate, blood pressure, and blood samples over several hours or days to see how your body responds. The total time commitment varies depending on the study schedule, but usually lasts from a few weeks to a couple of months, ending with a final health check.
Potential risks and benefits
Locations (1)
- Quotient Sciences LimitedCity onlyNottingham, England
Common questions
What is a Phase 1 clinical trial?
A Phase 1 trial is the earliest phase of testing in humans. It focuses on testing the safety of a new medicine, checking for side effects, and seeing how the body absorbs it.
What does 'deferred registration' mean?
It means the sponsor has permission from research regulators to keep full scientific details confidential for a limited time. The trial has still passed standard ethical and safety reviews.
Why does the study only include men aged 30 to 65?
Early safety trials often use narrow groups of people to keep the test results consistent and avoid confounding factors such as hormonal differences or age-related conditions.
Will I be paid for taking part?
Healthy volunteer trials usually provide payment to compensate you for your time, travel expenses, and any inconvenience caused by clinic visits.
Can I leave the study early if I change my mind?
Yes. Taking part is completely voluntary, and you can withdraw at any point without losing any of your standard medical care rights.
How to find out more
Clinical Study Director
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.